 James Bridges
Concepts (301)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 25 | 2024 | 3931 | 1.850 |
Why?
| | Pulmonary Surfactants | 6 | 2022 | 106 | 1.340 |
Why?
| | Receptors, G-Protein-Coupled | 6 | 2022 | 207 | 1.320 |
Why?
| | Alveolar Epithelial Cells | 5 | 2021 | 106 | 1.200 |
Why?
| | Respiratory Mucosa | 5 | 2025 | 307 | 1.090 |
Why?
| | Pulmonary Alveolar Proteinosis | 4 | 2024 | 17 | 1.080 |
Why?
| | Glucocorticoids | 6 | 2023 | 575 | 0.950 |
Why?
| | Betamethasone | 5 | 2023 | 20 | 0.890 |
Why?
| | Pulmonary Alveoli | 6 | 2025 | 400 | 0.850 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2019 | 821 | 0.800 |
Why?
| | Epithelial Cells | 6 | 2023 | 1065 | 0.780 |
Why?
| | Transduction, Genetic | 2 | 2021 | 128 | 0.750 |
Why?
| | Dependovirus | 2 | 2021 | 62 | 0.750 |
Why?
| | Signal Transduction | 12 | 2022 | 4925 | 0.710 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2025 | 636 | 0.690 |
Why?
| | Regeneration | 2 | 2021 | 180 | 0.680 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2017 | 147 | 0.670 |
Why?
| | Lipid Metabolism | 3 | 2024 | 497 | 0.670 |
Why?
| | Mice | 30 | 2024 | 16937 | 0.640 |
Why?
| | Animals | 44 | 2025 | 35361 | 0.600 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 274 | 0.580 |
Why?
| | Cell Adhesion | 2 | 2016 | 452 | 0.550 |
Why?
| | Lung Diseases | 4 | 2018 | 742 | 0.550 |
Why?
| | Cell Differentiation | 5 | 2023 | 1902 | 0.500 |
Why?
| | Sterol Regulatory Element Binding Proteins | 1 | 2014 | 3 | 0.460 |
Why?
| | Peptides | 3 | 2022 | 925 | 0.450 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 5 | 2021 | 44 | 0.450 |
Why?
| | Fetal Organ Maturity | 4 | 2022 | 27 | 0.440 |
Why?
| | Adrenal Cortex Hormones | 3 | 2020 | 522 | 0.390 |
Why?
| | Cell Membrane | 1 | 2016 | 732 | 0.380 |
Why?
| | Macrophages | 4 | 2024 | 1480 | 0.380 |
Why?
| | Lymphangiogenesis | 1 | 2011 | 26 | 0.380 |
Why?
| | Models, Animal | 2 | 2019 | 376 | 0.360 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 442 | 0.360 |
Why?
| | Protein Folding | 4 | 2009 | 266 | 0.360 |
Why?
| | Liver | 3 | 2019 | 1839 | 0.350 |
Why?
| | Morphogenesis | 2 | 2016 | 158 | 0.350 |
Why?
| | Macrophages, Alveolar | 6 | 2024 | 389 | 0.350 |
Why?
| | Membrane Proteins | 3 | 2014 | 1119 | 0.350 |
Why?
| | 1-Acylglycerophosphocholine O-Acyltransferase | 1 | 2010 | 5 | 0.340 |
Why?
| | Phospholipids | 2 | 2017 | 215 | 0.330 |
Why?
| | Genetic Vectors | 4 | 2021 | 312 | 0.320 |
Why?
| | Respiration | 1 | 2010 | 191 | 0.320 |
Why?
| | Cell Line | 9 | 2017 | 2781 | 0.320 |
Why?
| | Dexamethasone | 3 | 2020 | 346 | 0.310 |
Why?
| | Fibroblasts | 3 | 2025 | 948 | 0.310 |
Why?
| | Mice, Knockout | 7 | 2022 | 2871 | 0.290 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2282 | 0.290 |
Why?
| | Mice, Transgenic | 6 | 2017 | 2119 | 0.290 |
Why?
| | Lung Diseases, Interstitial | 2 | 2021 | 616 | 0.280 |
Why?
| | Pulmonary Fibrosis | 2 | 2024 | 386 | 0.250 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2006 | 52 | 0.250 |
Why?
| | Sheep | 4 | 2023 | 837 | 0.250 |
Why?
| | Endoplasmic Reticulum | 4 | 2010 | 261 | 0.240 |
Why?
| | Heat-Shock Proteins | 2 | 2008 | 136 | 0.220 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2019 | 148 | 0.210 |
Why?
| | Prenatal Care | 3 | 2022 | 276 | 0.210 |
Why?
| | Epigenomics | 1 | 2023 | 110 | 0.210 |
Why?
| | Humans | 31 | 2025 | 129652 | 0.200 |
Why?
| | Mutation | 7 | 2021 | 3717 | 0.200 |
Why?
| | Gene Expression Profiling | 5 | 2019 | 1706 | 0.190 |
Why?
| | Phosphatidylcholines | 2 | 2013 | 146 | 0.190 |
Why?
| | Cytokine Receptor Common beta Subunit | 2 | 2018 | 2 | 0.180 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2021 | 97 | 0.180 |
Why?
| | Capsid | 1 | 2020 | 90 | 0.170 |
Why?
| | Premature Birth | 2 | 2020 | 314 | 0.170 |
Why?
| | Macaca mulatta | 4 | 2021 | 149 | 0.160 |
Why?
| | Exons | 3 | 2013 | 342 | 0.160 |
Why?
| | Cell Proliferation | 4 | 2020 | 2391 | 0.160 |
Why?
| | Heparin | 1 | 2020 | 253 | 0.150 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 5440 | 0.150 |
Why?
| | Cholesterol | 2 | 2018 | 412 | 0.150 |
Why?
| | Lipids | 4 | 2024 | 625 | 0.150 |
Why?
| | Amino Acids | 1 | 2022 | 485 | 0.150 |
Why?
| | tau Proteins | 1 | 2019 | 78 | 0.150 |
Why?
| | Receptors, Glucocorticoid | 1 | 2020 | 147 | 0.150 |
Why?
| | Amyloid | 1 | 2019 | 85 | 0.150 |
Why?
| | Gene Expression | 3 | 2017 | 1472 | 0.150 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2018 | 33 | 0.150 |
Why?
| | Fetal Development | 1 | 2021 | 288 | 0.150 |
Why?
| | Delivery, Obstetric | 1 | 2019 | 137 | 0.150 |
Why?
| | Acyl-CoA Oxidase | 1 | 2018 | 2 | 0.150 |
Why?
| | Disease Models, Animal | 7 | 2020 | 4063 | 0.150 |
Why?
| | Memory Disorders | 1 | 2019 | 168 | 0.150 |
Why?
| | Lymphocytes | 1 | 2020 | 377 | 0.140 |
Why?
| | Erythroblasts | 1 | 2017 | 15 | 0.140 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2018 | 71 | 0.140 |
Why?
| | Polycythemia | 1 | 2017 | 22 | 0.140 |
Why?
| | Receptors, Erythropoietin | 1 | 2017 | 20 | 0.140 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2020 | 307 | 0.140 |
Why?
| | Transgenes | 2 | 2011 | 177 | 0.140 |
Why?
| | Lymphohistiocytosis, Hemophagocytic | 1 | 2017 | 29 | 0.140 |
Why?
| | Pseudomonas Infections | 1 | 2019 | 221 | 0.140 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2017 | 133 | 0.140 |
Why?
| | Myelodysplastic Syndromes | 1 | 2018 | 129 | 0.130 |
Why?
| | Biomarkers | 5 | 2023 | 3973 | 0.130 |
Why?
| | Immunohistochemistry | 3 | 2012 | 1698 | 0.130 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2018 | 125 | 0.130 |
Why?
| | Pseudomonas aeruginosa | 1 | 2019 | 347 | 0.130 |
Why?
| | Neovascularization, Physiologic | 2 | 2009 | 176 | 0.130 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2015 | 9 | 0.130 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2018 | 272 | 0.120 |
Why?
| | Genetic Diseases, Inborn | 1 | 2015 | 38 | 0.120 |
Why?
| | Influenza, Human | 1 | 2021 | 601 | 0.120 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2016 | 139 | 0.120 |
Why?
| | Fetus | 1 | 2019 | 773 | 0.120 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2017 | 644 | 0.120 |
Why?
| | Transfection | 3 | 2009 | 911 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 261 | 0.120 |
Why?
| | Gene Deletion | 3 | 2019 | 379 | 0.120 |
Why?
| | Salivary Glands | 1 | 2014 | 29 | 0.110 |
Why?
| | Molecular Chaperones | 2 | 2008 | 182 | 0.110 |
Why?
| | Transcription, Genetic | 2 | 2016 | 1418 | 0.110 |
Why?
| | Respiratory Insufficiency | 1 | 2017 | 313 | 0.110 |
Why?
| | Animals, Newborn | 3 | 2021 | 835 | 0.110 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 430 | 0.110 |
Why?
| | Pregnancy | 6 | 2023 | 6402 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2020 | 804 | 0.110 |
Why?
| | Receptors, Purinergic P2Y2 | 1 | 2013 | 6 | 0.110 |
Why?
| | Calcinosis | 1 | 2015 | 230 | 0.110 |
Why?
| | Cytomegalovirus | 1 | 2014 | 154 | 0.110 |
Why?
| | Hermanski-Pudlak Syndrome | 1 | 2012 | 2 | 0.100 |
Why?
| | Liver Neoplasms | 1 | 2018 | 640 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 901 | 0.100 |
Why?
| | Internet | 1 | 2017 | 617 | 0.100 |
Why?
| | Computational Biology | 1 | 2017 | 599 | 0.100 |
Why?
| | Analysis of Variance | 2 | 2012 | 1288 | 0.100 |
Why?
| | Immune Sera | 1 | 2011 | 86 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2011 | 17 | 0.090 |
Why?
| | Glycogen | 1 | 2011 | 55 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2011 | 530 | 0.090 |
Why?
| | Doxycycline | 1 | 2011 | 60 | 0.090 |
Why?
| | Luciferases | 3 | 2009 | 148 | 0.090 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2011 | 146 | 0.090 |
Why?
| | Hypoxia | 1 | 2018 | 1084 | 0.090 |
Why?
| | Immunoblotting | 1 | 2011 | 305 | 0.090 |
Why?
| | Protein Transport | 3 | 2012 | 428 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 331 | 0.090 |
Why?
| | DNA Primers | 1 | 2011 | 510 | 0.090 |
Why?
| | DNA, Mitochondrial | 1 | 2011 | 191 | 0.090 |
Why?
| | Air | 1 | 2010 | 36 | 0.080 |
Why?
| | Regulatory Factor X Transcription Factors | 2 | 2008 | 10 | 0.080 |
Why?
| | Receptors, Adenosine A2 | 1 | 2009 | 5 | 0.080 |
Why?
| | Injections, Intramuscular | 2 | 2019 | 116 | 0.080 |
Why?
| | Protein Structure, Secondary | 1 | 2010 | 341 | 0.080 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2010 | 103 | 0.080 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2008 | 24 | 0.070 |
Why?
| | Epitopes | 1 | 2010 | 470 | 0.070 |
Why?
| | Models, Biological | 2 | 2017 | 1722 | 0.070 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 237 | 0.070 |
Why?
| | Phenotype | 3 | 2017 | 3076 | 0.070 |
Why?
| | Homeostasis | 2 | 2023 | 611 | 0.070 |
Why?
| | Administration, Oral | 2 | 2019 | 786 | 0.070 |
Why?
| | Female | 11 | 2023 | 68777 | 0.070 |
Why?
| | Microscopy, Fluorescence | 2 | 2009 | 400 | 0.070 |
Why?
| | Transcription Factors | 3 | 2017 | 1651 | 0.070 |
Why?
| | Leupeptins | 1 | 2006 | 9 | 0.060 |
Why?
| | Protein Sorting Signals | 1 | 2006 | 19 | 0.060 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2006 | 49 | 0.060 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2012 | 964 | 0.060 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2006 | 21 | 0.060 |
Why?
| | Proteasome Inhibitors | 1 | 2006 | 42 | 0.060 |
Why?
| | I-kappa B Proteins | 1 | 2006 | 74 | 0.060 |
Why?
| | Blotting, Western | 2 | 2009 | 1205 | 0.060 |
Why?
| | Protein Processing, Post-Translational | 1 | 2008 | 455 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2012 | 1181 | 0.060 |
Why?
| | Protein Binding | 3 | 2009 | 2121 | 0.060 |
Why?
| | Caspase 3 | 1 | 2006 | 245 | 0.060 |
Why?
| | Caspases | 1 | 2006 | 245 | 0.060 |
Why?
| | Promoter Regions, Genetic | 3 | 2019 | 1207 | 0.060 |
Why?
| | Infant, Newborn | 2 | 2020 | 5762 | 0.060 |
Why?
| | Blood Vessels | 1 | 2006 | 187 | 0.060 |
Why?
| | Hippocampus | 2 | 2019 | 874 | 0.060 |
Why?
| | Oligopeptides | 1 | 2006 | 257 | 0.060 |
Why?
| | Endothelial Cells | 1 | 2009 | 749 | 0.050 |
Why?
| | Down-Regulation | 1 | 2006 | 636 | 0.050 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 1052 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 270 | 0.050 |
Why?
| | Pneumonia | 2 | 2020 | 616 | 0.050 |
Why?
| | Up-Regulation | 1 | 2006 | 840 | 0.050 |
Why?
| | Cell Survival | 1 | 2006 | 1086 | 0.050 |
Why?
| | Transcriptome | 2 | 2019 | 887 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2018 | 1356 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2008 | 1443 | 0.050 |
Why?
| | Lung Neoplasms | 2 | 2012 | 2344 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2003 | 375 | 0.050 |
Why?
| | Gene Knock-In Techniques | 1 | 2021 | 53 | 0.050 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2021 | 52 | 0.050 |
Why?
| | Steroids | 1 | 2022 | 158 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2023 | 2535 | 0.050 |
Why?
| | Nuclear Proteins | 1 | 2006 | 663 | 0.040 |
Why?
| | Time Factors | 2 | 2019 | 6556 | 0.040 |
Why?
| | Fibrosis | 1 | 2023 | 520 | 0.040 |
Why?
| | Sepharose | 1 | 2020 | 33 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 594 | 0.040 |
Why?
| | Chorioamnionitis | 1 | 2020 | 40 | 0.040 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 1 | 2020 | 6 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2023 | 2708 | 0.040 |
Why?
| | Receptor, IGF Type 1 | 1 | 2020 | 65 | 0.040 |
Why?
| | Capsid Proteins | 1 | 2020 | 90 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 958 | 0.040 |
Why?
| | Cytokines | 2 | 2018 | 2017 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2020 | 45 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2003 | 743 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 577 | 0.040 |
Why?
| | Biological Availability | 1 | 2019 | 147 | 0.040 |
Why?
| | Diet | 2 | 2018 | 1213 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 2012 | 0.040 |
Why?
| | Infusions, Intravenous | 1 | 2019 | 400 | 0.040 |
Why?
| | Inflammation | 2 | 2020 | 2736 | 0.040 |
Why?
| | Bronchoalveolar Lavage | 1 | 2018 | 92 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1587 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2019 | 121 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 241 | 0.040 |
Why?
| | Capillary Leak Syndrome | 1 | 2017 | 12 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 333 | 0.040 |
Why?
| | Gene Order | 1 | 2017 | 26 | 0.040 |
Why?
| | Surface-Active Agents | 1 | 2018 | 84 | 0.040 |
Why?
| | Cell Death | 1 | 2019 | 354 | 0.040 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 51 | 0.040 |
Why?
| | RNA Interference | 2 | 2009 | 448 | 0.040 |
Why?
| | Point Mutation | 1 | 2018 | 225 | 0.030 |
Why?
| | Cell Count | 1 | 2017 | 314 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2017 | 267 | 0.030 |
Why?
| | Hepatocytes | 1 | 2018 | 216 | 0.030 |
Why?
| | Apoptosis | 1 | 2006 | 2503 | 0.030 |
Why?
| | Erythropoietin | 1 | 2017 | 86 | 0.030 |
Why?
| | DNA | 1 | 2003 | 1400 | 0.030 |
Why?
| | Neuronal Plasticity | 1 | 2019 | 280 | 0.030 |
Why?
| | Placenta | 1 | 2023 | 723 | 0.030 |
Why?
| | PPAR gamma | 1 | 2017 | 183 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2017 | 161 | 0.030 |
Why?
| | Gestational Age | 1 | 2019 | 874 | 0.030 |
Why?
| | Fear | 1 | 2019 | 350 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 280 | 0.030 |
Why?
| | Infant, Premature | 1 | 2020 | 541 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2017 | 504 | 0.030 |
Why?
| | Metabolome | 1 | 2018 | 338 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 2017 | 412 | 0.030 |
Why?
| | Male | 5 | 2020 | 63682 | 0.030 |
Why?
| | Learning | 1 | 2019 | 403 | 0.030 |
Why?
| | Fatty Acids | 1 | 2018 | 427 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 413 | 0.030 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2020 | 378 | 0.030 |
Why?
| | Phosphates | 1 | 2015 | 180 | 0.030 |
Why?
| | Epithelium | 1 | 2015 | 311 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 505 | 0.030 |
Why?
| | Killer Cells, Natural | 1 | 2017 | 427 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2017 | 770 | 0.030 |
Why?
| | Adaptor Protein Complex 3 | 1 | 2012 | 3 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1488 | 0.030 |
Why?
| | Software | 1 | 2017 | 608 | 0.020 |
Why?
| | Mitochondria | 1 | 2018 | 877 | 0.020 |
Why?
| | Developmental Disabilities | 1 | 2014 | 261 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1245 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2012 | 189 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 14518 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2012 | 317 | 0.020 |
Why?
| | Bleomycin | 1 | 2012 | 244 | 0.020 |
Why?
| | Synapses | 1 | 2014 | 400 | 0.020 |
Why?
| | Pneumonectomy | 1 | 2012 | 151 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 648 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 485 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2635 | 0.020 |
Why?
| | Microscopy, Immunoelectron | 1 | 2009 | 43 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2018 | 1928 | 0.020 |
Why?
| | Amino Acids, Dicarboxylic | 1 | 2009 | 8 | 0.020 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2009 | 55 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 132 | 0.020 |
Why?
| | Response Elements | 1 | 2009 | 90 | 0.020 |
Why?
| | Survival Analysis | 1 | 2012 | 1274 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2012 | 1201 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 310 | 0.020 |
Why?
| | Valosin Containing Protein | 1 | 2008 | 4 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2009 | 235 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1295 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1502 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2548 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2008 | 99 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2008 | 157 | 0.020 |
Why?
| | Cytosol | 1 | 2008 | 218 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2012 | 1838 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 161 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2012 | 1952 | 0.020 |
Why?
| | Aged | 2 | 2018 | 22104 | 0.020 |
Why?
| | Binding Sites | 1 | 2009 | 1252 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 769 | 0.020 |
Why?
| | Obesity | 1 | 2018 | 2883 | 0.010 |
Why?
| | Cell Movement | 1 | 2009 | 945 | 0.010 |
Why?
| | Middle Aged | 2 | 2018 | 31155 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2008 | 586 | 0.010 |
Why?
| | Registries | 1 | 2012 | 1896 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2012 | 4897 | 0.010 |
Why?
| | Risk Assessment | 1 | 2012 | 3240 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 5420 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4083 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5500 | 0.010 |
Why?
| | Neoplasms | 1 | 2014 | 2470 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2012 | 10230 | 0.010 |
Why?
| | Insulin | 1 | 2008 | 2326 | 0.010 |
Why?
| | Adult | 1 | 2017 | 35577 | 0.010 |
Why?
|
|
Bridges's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|